Measurement of hypoxanthine incorporation in purified suspensions of Mycobacterium leprae: a suitable method to screen for anti-leprosy agents in vitro

References

1. Ambrose E J, Khanolkar S R, Chulawalla R G. 1978; A rapid test for bacillary resistance to dapsone. Leprosy in India 50:131–143
   [Google Scholar]
2. Bruce I, Hardy J, Stacey K A. 1984; Potentiation by purines of the growth inhibitory effects of sulphonamides on Escherichia coli K12 and the location of the gene which mediates this effect. Journal of General Microbiology 130:2489–2495
   [Google Scholar]
3. Cartel J L, Millan J, Guelpa-Lauras C C, Grosset J H. 1983; Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide. International Journal of leprosy 51:461–465
   [Google Scholar]
4. Colquhoun D. 1971; Numerical and rank measurements. Lectures on Biostatistics Clarendon Press; Oxford:137–151
   [Google Scholar]
5. Colston M J, Hilston G R F, Banerjee D K. 1978; The “proportional bactericidal test”: a method for assessing bactericidal activity of drugs against Mycobacterium leprae in mice. leprosy Review 49:7–15
   [Google Scholar]
6. Ellard G A. 1974; Growing points in leprosy research. 4. Recent advances in the chemotherapy of leprosy. Leprosy Review 45:31–40
   [Google Scholar]
7. Guelpa-Lauras C C, Grosset J H, Constant-Desportes M, Brucker G. 1984; Nine cases of rifampin-resistant leprosy. International Journal of Leprosy 52:101–102
   [Google Scholar]
8. Khanolkar S R, Wheeler P R. 1983; Purine metabolism in Mycobacterium leprae grown in armadillo liver. FEMS Microbiology Letters 20:273–278
   [Google Scholar]
9. Kulkarni V M, Seydel J K. 1983; Inhibitory activity and mode of action of diaminodiphenylsulfone in cell-free folate synthesizing systems prepared from Mycobacterium lufu and Mycobacterium leprae : a comparison. Chemotherapy 29:58–67
   [Google Scholar]
10. Kvach J T, Munguia G, Strand S H. 1984; Staining tissue derived Mycobacterium leprae with fluorescein diacetate and ethidium bromide. International Journal of Leprosy 52:176–182
    [Google Scholar]
11. Mankar M V, Jagannathan R, Mahadevan P R. 1984; In vitro drug screening system using membrane alteration in macrophages by Mycobacterium leprae. Journal of Biosciences 6:709–716
    [Google Scholar]
12. Mittal A, Sathish M, Seshadri P S, Nath I. 1983; Rapid, radiolabeled-microculture method that uses macrophages for in vitro evaluation of Mycobacterium leprae viability and drug susceptibility. Journal of Clinical Microbiology 17:704–707
    [Google Scholar]
13. Murohashi T, Yoshida K. 1975; Attempts to culture Mycobacterium leprae in culture media. Acta Leprologica 58:5–21
    [Google Scholar]
14. Nair I, Mahadevan P R. 1984; An in vitro test using cholesterol metabolism of macrophages to determine drug sensitivity and resistance of Mycobacterium leprae. Journal of Biosciences 6:221–231
    [Google Scholar]
15. Nakamura M. 1982; Failure to validate the growth of Mycobacterium leprae on M-Y 14b agar medium. International Journal of Leprosy 50:480–487
    [Google Scholar]
16. Nam Lee Y, Colston M J. 1985; Measurement of ATP generation and decay in Mycobacterium leprae in vitro. Journal of General Microbiology 131:3331–3337
    [Google Scholar]
17. Nath I, Prasad H K, Sathish M, Sreevatsa S., Desikan K V, Seshadri P S, Iyer C G S. 1982; Rapid radiolabeled macrophage culture method for detection of dapsone-resistant Mycobacterium leprae. Antimicrobial Agents and Chemotherapy 21:26–32
    [Google Scholar]
18. Pattyn S R. 1984; Hepatoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy. International Journal of Leprosy 52:1–6
    [Google Scholar]
19. Seydel J K, Wempe E G, Rosenfeld M. 1983; Bacterial growth kinetics of Escherichia coli and mycobacteria in the presence of brodimoprim and metioprim alone and in combination with sulfamerazine and dapsone. Chemotherapy 29:249–261
    [Google Scholar]
20. Sharp A K, Colston M J, Banerjee D K. 1985; Susceptibility of Mycobacterium leprae to the bactericidal activity of mouse peritoneal macrophages and to hydrogen peroxide. Journal of Medical Microbiology 19:77–84
    [Google Scholar]
21. Shepard C C. 1960; The experimental disease that follows the injection of human leprosy bacilli into footpads of mice. Journal of Experimental Medicine 112:445–453
    [Google Scholar]
22. Warndorff-van Diepen T. 1982; Clofazimine-resistant leprosy— a case report. International Journal of Leprosy 50:139–142
    [Google Scholar]
23. Wheeler P R. 1983; Catabolic pathways for glucose, glycerol and 6-phosphogluconate in Mycobacterium leprae grown in armadillo tissues. Journal of General Microbiology 129:1481–1495
    [Google Scholar]
24. World Health Organization 1980; UNDP/World Bank/WHO Special programme for research and training in tropical diseases. Report of the fifth meeting of the scientific working group on the immunology of leprosy (IMMLEP). TDR/IMMLEP-SWG(5)/80-3 Annex 4 World Health Organization; Geneva:23
    [Google Scholar]
25. World Health Organization 1985; UNDP/World Bank/WHO Special programme for research and training in tropical diseases. Tropical disease research, seventh programme report (1 January 1983-31 December 1984). Leprosy Chapter 8 World Health Organization; Geneva:
    [Google Scholar]